期刊文献+

淀粉样变性心肌病268例临床分析 被引量:3

Clinical analysis on 268 cases of cardiac amyloidosis:a literature review(2000 to 2009)
在线阅读 下载PDF
导出
摘要 目的总结淀粉样变性心肌病(cardiac amyloidosis,CA)的临床特点、诊治方法 ,为临床进一步认识和诊治该病提供依据。方法检索中国期刊全文数据库(CNKI)、西文生物医学文献数据库、万方数据库和pubmed,收集2000年1月至2009年10月发表的相关病例报告,进行回顾性调查研究。结果①经检索共筛选出相关文献44篇计268例;②CA可发生于任何年龄,多见于中老年,男性发病率明显高于女性(2.67∶1);③临床表现最常见的是进行性的心力衰竭(67.1%),其中双下肢水肿(54.3%),气短(44.5%),肝大(39.0%),颈静脉怒张(34.8%);其次为类似心绞痛的症状——胸闷胸痛(25.6%),心血管系统以外最常受累的是肾脏(37.2%);④临床上易被误诊,其中58.9%误诊为肥厚性心肌病,28.8%误诊为限制性心肌病。⑤心肌病理活检为确诊方法 ,心电图、心脏彩色超声和磁共振是诊断CA主要的辅助检查,其中磁共振有望成为一种新的无创确诊方法。⑥CA患者合并心力衰竭多预后不良。结论 CA临床表现多样化,易误诊为肥厚性心肌病和限制性心肌病,且合并心力衰竭时多预后不良,应及早发现与诊治。 Objective To comprehend the clinical characteristics and treatment of present status of cardiac amyloidosis.Methods Literatures on cardiac amyloidosis published in journals between January 2000 and October 2009 were identified by searching CNKI,Wanfang,pubmed and FMJS.Retrospective review was done.Results ①A total of 44 literatures with 268 cardiac amyloidosis patients were found.②Cardiac amyloidosis occurred in any age,especially the middle or elder people.The male incidence was obviously higher than female with the rate of 2.67∶1.③The most common clinical manifestation was progressively congestive heart failure(67.1%),such as edema of both lower extremities(54.3%),dyspnea(44.5%),hepatomegaly(39.0%) and distention of jugular vein(34.8%).The other common symptom was chest pain(25.6%).Out of cardiovascular system,kidney(37.2%) was the most affected organ.④Cardiac amyloidosis was fallibility misdiagnosed multiple diseases,such as hypertrophic cardiomyopathy(58.9%) and restrictive cardiomyopathy(28.8%).⑤Endomyocardial biopsy was the final diagnostic method.Electrocardiogram,echocardiogram and cardiovascular magnetic resonance imaging(CMRI) were important auxiliary examinations.It is possible that CMRI becomes a new noninvasive diagnostic method.⑥The cases with congestive heart failure had a poor prognosis.Conclusion The clinical characteristics of cardiac amyloidosis are multiple,can be fallibility misdiagnosed,such as hypertrophic cardiomyopathy and restrictive cardiomyopathy.Cardiac amyloidosis has a poor prognosis,especially with congestive heart failure.It is essential to diagnose and treat as early as possible.
出处 《临床荟萃》 CAS 2010年第13期1115-1118,共4页 Clinical Focus
关键词 心肌疾病 淀粉样变性 病理状态 体征和症状 cardiomyopathies amyloidosis pathological conditions signs and symptoms
  • 相关文献

参考文献13

  • 1刘紫燕,邱原刚.心脏淀粉样变性[J].心血管病学进展,2007,28(6):896-899. 被引量:9
  • 2李中言,马丽萍,关青.心脏淀粉样变性[J].解放军医学情报,1995,9(4):178-180. 被引量:3
  • 3Rabman JE, Helou EF, Gelzer-Bell R, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis[J]. J Am Coll Cardiol,2004,43(3) :410-415.
  • 4Hassan W, A1-Sergani H, Mourad W, et al. Amyloid heart disease, new frontiers and insights in pathophysiolgy, diagnosis,andmanagement[J].TexHeart Inst J,2005,32(2): 178-184.
  • 5Liao R,Jain M, Teller P, et al. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts [J]. Circulation, 2001,104 ( 14 ) : 1594-1597.
  • 6Murtagh B, Hammill SC,Gertz MA,et al. Electrocardiographic findings in primany systemic amyloidosis and biopsy-proven cardiac involvenment[J]. Am J Cardiol, 2005,95 (4) : 535-537.
  • 7Falk RH. Diagnosis and management of the cardiac amyloidoses[ J ]. Circulation,2005,112(13) 2047- 2060.
  • 8Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review [J]. Arch Intern Med, 2006, 166 ( 17 ) : 1085-1813.
  • 9Gertz MA. The classification and typing of amyloid deposits [J]. Am J Clin Pathol, 2004,121 (6) : 787-789.
  • 10Cuy CD, Jones CK. Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis:specificity, positive predictive value, and diagnostic pitfalls[J]. Diagn Cytoparhol, 2001,24(3) : 181-185.

二级参考文献30

  • 1NEBEN-WITTICH M A,WITTICH C M,MUELLER P S,et al.Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis[J].Am J Med,2005; 118:1287-1287.
  • 2Kasper DL,Braunwald E,Fauci AS, et al. Harrison's Principles of Internal Medicine[ M]. 16th ed. New York: The Mcgraw-Hill Companies Inc,2005. 2024- 2029.
  • 3Goldman L,Ausiello D. Cecil Textbook of Medicine[ M ]. 22th ed. Philadelphia: Saunders ,2004. 1713-1716.
  • 4Connors LH, Lim A, Prokaeva T,et al. Tabulation of human transthyretin ( TTR ) variants[J]. Amyloid ,2003,10: 160-184.
  • 5Herlenius G ,Wilczek HE ,Larsson M ,et al. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy:resuhs from the Familial Amyloidotic Polyneuropathy World Transplant Registry [ J ]. Transplantation ,2004,77:64-71.
  • 6Chung CM, Connors LH, Benson MD, et al. Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis [ J ]. Amyloid ,2001,8:75-83.
  • 7Kholova I,Niessen HWM. Amyloid in the cardiovascular system : a review [ J ]. Clin Pathol,2005,58 : 125-133.
  • 8Hazenberg BPC, Gameren II van, Bijzit J, et al. Diagnostic and therapeutic approach of systemic amyloidosis [J]. N Engl J Med,2004,62: 121-128.
  • 9Hofer JF, Wimmer G. Severe heart failure from light chain cardiomyopathy (cardiac amyloidosis) [J]. Z Kardiol,2003,92: 90-95.
  • 10Dingli D,Utz JP Gertz MA. Pulmonary hypertension in patients with amyloidos s [ J]. Chest ,2001,120 : 1735-1738.

共引文献12

同被引文献29

  • 1陈刘婷,姜洪.心脏磁共振在心肌病中的应用进展[J].中华临床医师杂志(电子版),2012,6(16):4814-4815. 被引量:4
  • 2Rabman JE, Helou EF, Gelzer-Bell R, et al Noninvasive diagnosis of biopsy-proven cardiac amyloidosis[J]. J Am Coil Cardio1,2004,43(3) :410-415.
  • 3Apridonidze T, Steingart RM, Comenzo RL, et al. Clinical and echocardiographic correlates of elevated troponin in amyloid light- chain cardiac amyloidosis. Am J Cardio1,2012,110 : 1180-1184.
  • 4Selvanayagam JB, Hawkins PN, Paul B, et al. Evaluation and management of the cardiac amyloidosis. J Am Coil Cardiol,2007, 50:2101-2110.
  • 5Austin BA, Duffy B, Tan C, et al. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol,2009,103 : 1429-1433.
  • 6Murtagh B, Hammill SC, Gertz MA, et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol, 2005,95:535-537.
  • 7Murtagh B, Hammill SC, Gertz MA, et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.Am J Cardiol, 2005,95:535-537.
  • 8Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation ,2005,112:2047-2060.
  • 9Falk RH, Plehn JE, Deering T, et al. Sensitivity and specificity of the eehocardiographic features of cardiac amyloidosis. Am J Cardiol, 1987,59:418-422.
  • 10Chau EM, Chow WH, Wang E, et al. Cardiac amyloidosis- experience in a tertiary cardiac referral centre. Int J Cardio1,2008, 124 : 264 -266.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部